2023/01/16: Affluent Medical strengthens its management team to support industrial and commercial deployment
PRESS RELEASE Affluent Medical strengthens its management team to support industrial and commercial deployment ... | January 16, 2023
PRESS RELEASE Affluent Medical increases its management team to support commercial and industrial deployment Aix-en-Provence (16 January 2023 - 5 :45 - Affluent Medical) (ISIN code FR0013333077 - ticker AFME), a French MedTech specializing on the international development and industrialization innovative medical devices. It announced, after the arrival of Christophe Giot VP Clinical Affairs in the second half 2022, the appointment of three members to the management committee. This will prepare for the industrialization and the marketing and the three new medical devices: Kalios Artus, Epygon, Artus, Epygon, Kalios and Artus, Epygon. Celine Buard – Marketing Director Celine Buard is a graduate of ESCP Paris and holds a DU (Nutrition and Metabolic Diseases) from the University of Medicine Rennes. Celine Buard worked for 15 years in various sales and marketing roles in major healthcare organizations like Johnson&Johnson and Medtronic. Her contributions to the development of projects have been significant in Europe, Latin America and the United States in various clinical areas (gynecology/urology, general surgery, gynecology/urology, diabetes, ophthalmology). Celine managed the Johnson&Johnson urinary incontinence product lines for many years. Celine, who spent 5 years at Eyetechcare in marketing and sales director roles, joined Truffle Capital as a Truffle Capital investor in June 2022. She also completed her cardiovascular experience with Caranx Medical. Since November 2022, she brings her experience in marketing to the Affluent Medicine team. Olivier Belamy, Industrialization Director Olivier Belamy is a former manager in large pharmaceutical companies where he was involved in organizational, industrial performance, and asset valuation. Olivier previously served as the COO of Robocath Robotics and Ecential Robotics. These companies specialize in robotics for interventional cardiology. His responsibilities included industrial development, including the organization of industrialization and production processes. Claire Andre - Quality Assurance manager Claire Andre has over 15 years experience in quality management in the medical device and pharmaceutical industries. Claire Andre was previously a quality manager in medical device companies that developed and marketed class III medical devices. She was most notable for her work at Perouse Medical, which designs, manufactures, and markets long-term vascular access and cardiovascular medical devices. Between 2018 and 2022 she joined Fill-MedLaboratories, a major player for anti-agingmedical and cosmetic products. Claire Andre's career has been characterized by a solid background in injectable and implantable products as well as the associated standards and regulations. 1/2 COMMUNIQUE de PRESSE Sebastien Ledet, CEO, Affluent Medical said that Claire, Olivier, and Celine joined Affluent Medical during a crucial time in the Group's history. Affluent Medical continues the clinical development of three new medical devices. Affluent Medical has a team that is highly experienced and complementing to prepare for the next steps in industrialization. Affluent Medical is currently looking into the best financing options for the next stage of its development. Affluent Medical, which is especially attentive to the equity market conditions, plans to increase its capital during the first half 2023 with all of its shareholders. This operation would help to fund the company's clinical programs. It would also benefit from the support and assistance of its reference shareholder. Four major technologies that the company has developed are currently being tested in clinical and preclinical studies. KaliosTM will be the first European medical device to go on sale. For more information, please visit URL Contacts: AFFLUENTMEDICALACTIFIN. Financial communications Sebastien LADT Ghislaine GASPARETTO Chief Executive Officer +33(0)6 21 10 49 24, EMAIL, EMAIL, ACTIFIN. Financial press relations PRIME, Public relations France Isabelle ROBOREL de CLIMENS +33(0)1 5688 11 29, +33(0)6 78 12 9795 EMAIL___________________________________ Original Link Original Document Permalink
Disclaimer Affluent Medical SA published the content on 16/01/2023. It is solely responsible. Published by Public at 16:59:07 UTC.
Duration: Auto. 2 months 3 months 6 month 9 months 1 year 2years 5 years 10 years max. Period : Day Week
Short TermMid-TermLong TermTrendsBearishBearishBearish